Alkem Laboratories Q2 Results 2025 Highlights: Net Profit Surged by 11.10% & Revenue Up 17.17% YoY

Click and Sign Up to Get Live Updates on Q2 Results 

Alkem Laboratories Q2 Results FY26: During Q2 FY26, Alkem Laboratories’ profit increased 11.10% YoY, while revenue increased by 17.17% YoY. The company posted robust numbers, with Q2 PAT at ₹765.06 crores and revenue at ₹4,000.99 crores. Alkem Laboratories showed its Q2 results on 13th November 2025.  

Alkem Laboratories Q2 Results FY26: Extracts of FY25 & FY26

Alkem Laboratories Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

• Alkem Laboratories clocked Q2 FY26 consolidated revenue of ₹4,000.99 crores vs ₹3,414.67 crores. 
• On the profit front, Alkem Laboratories earned a consolidated PAT of ₹765.06 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹688.64 crore.
• According to the consolidated figures, Alkem Laboratories’ quarterly PAT increased by 11.10% YoY, while revenue increased by 17.17%.
• Alkem Laboratories clocked Q2 FY26 standalone revenue of ₹2,542.03 crores vs ₹2,354.72 crores. 
• On the profit front,  Alkem Laboratories earned a standalone PAT of ₹723.66 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹641.85 crore.
• According to the standalone figures,  Alkem Laboratories’ quarterly PAT increased by 12.75% YoY, while revenue increased by 7.95%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces! 

Alkem Laboratories Share Price Performance 

On the opening bell on 19th November 2025,  Alkem Laboratories shares opened at ₹5,730.00 per share. However, the initial gains have since eroded, and Alkem Laboratories shares are currently trading at ₹5,714.00 per share, below the opening price.    

Considering the long-term achievements, Alkem Laboratories shares have yielded returns of approximately 7.38% over the past 6 months and 3.39% over the past 1 year. Over the maximum timeframe, Alkem Laboratories shares delivered a 275.23% return to investors. 

What Analysts Expect Post Q2 Results?

Following Alkem Laboratories’ robust Q2 results for FY26, analysts expect its share price to rise. According to analysts, Alkem Laboratories’ share price could reach ₹5,850.00 per share in the coming year and, in a downturn, could hit ₹5,685.30 per share. However, one must ignore stock market volatility and invest in  Alkem Laboratories shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here